Lyra Therapeutics, Inc. (LYRA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Lyra Therapeutics, Inc. (LYRA)
Go deeper and ask any question about LYRA
Company Performance
Current Price
as of Sep 13, 2024$0.28
P/E Ratio
N/A
Market Cap
$18.33M
Description
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Metrics
Overview
- HQWatertown, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerLYRA
- Price$0.28+7.69%
Trading Information
- Market Cap$18.33M
- Float86.16%
- Average Daily Volume (1m)860,388
- Average Daily Volume (3m)1,310,543
- EPS-$1.63
Company
- Revenue$1.82M
- Rev Growth (1yr)30.57%
- Net Income-$48.13M
- Gross Margin75.75%
- EBITDA Margin-2,953.18%
- EBITDA-$17.66M
- EV-$12.64M
- EV/Revenue-6.94
- P/EN/A
- P/S10.07
Documents
SEC Filings